Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-α in LPS-stimulated monocytes in human whole-blood

Cytokine

Volumn 62, Issue 1, 2013, Pages 52-57

  Raspe C ^a   Czeslick, E ^b   Weimann, A ^b   Schinke, C ^c   Leimert, A ^a   Kellner, P ^a   Simm, A ^a   Bucher, M ^a   Sablotzki, A ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Klinikum St Georg   (Germany)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

Cytokines; Endotoxemia; L Glutamine; Monocytes; Whole blood

Indexed keywords

ALANINE; ALANYLGLUTAMINE; GLUTAMINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE COUNT; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; ALANINE; DIPEPTIDES; ENDOTOXEMIA; FLOW CYTOMETRY; GLUTAMINE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTRACELLULAR SPACE; LIPOPOLYSACCHARIDES; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875810071     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.020     Document Type: Article

References (30)

1. Christensen N.H. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990, 70:43-77.
2. Neu J., Shenoy V., Chakrabarti R. Glutamine nutrition and metabolism: where do we go from here?. FASEB J 1996, 829-837.
3. Meister A. Metabolism of glutamine. Physiol Rev 1956, 36:103-127.
4. Griffiths R.D. Evidence for glutamine use in the critically ill. Proc Nutr Soc 2001, 60:403-410.
5. Bongers T., Griffiths R.D., McArdle A. Exogenous glutamine; the clinical evidence. Crit Care Med 2007, 35:S545-S552.
6. Griffiths R.D., Jones C., Palmer T.E., et al. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
7. Houdijk A., Rijnsburger E., Jansen J., et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. The Lancet 1998, 352:1-5.
8. Singer Pierre, Berger Mette M., Van den Berghe Greet, Biolo Gianni, Calder Philip, Forbes Alastair, et al. ESPEN Guidelines on parenteral nutrition: intensive care. Clin Nutr 2009, 28:387-400.
9. Dokladny K., Lobb R., Wharton W., Ma T.Y., Moseley P.L. LPS-induced cytokine levels are repressed by elevated expression of HSP70 in rats: possible role of NF-kappaB. Cell Stress Chaperones 2010, 15(2):153-163.
10. Wischmeyer P.E., Riehm J., Singleton K.D., Ren H., Musch M.W., Kahana M., et al. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 2003, 19(1):1-6.
11. Wang L.M., Pan L.Y., Zhang F., Wang X.Y., Li J.S. Mechanism of glutamine downregulates the cytokine expression in lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Zhonghua Wai Ke Za Zhi 2009, 47(20):1578-1580.
12. Hagiwara E., Abbasi F., Mor G., et al. Phenotype and frequency of cells secreting IL-2, IL-4, Il-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine 1995, 7(8):815.
13. Czeslick E.G., Simm A., Grond S., Silber R.E., Sablotzki A. Inhibition of intracellular tumour necrosis factor (TNF)-α and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Invest 2003, 33:1013.
14. Czeslick E., Struppert A., Simm A., Sablotzki A. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes. Inflamm. Res. 2006, 55:511-515.
15. Kew S., Wells S.M., Yaqoob P., et al. Dietary glutamine enhances murine T-lymphocyte responsiveness. J Nutr 1999, 129:1524-1531.
16. Murphy C., Newsholme P. Macrophage-mediated lysis of a b-cell line, tumour necrosis factor-a release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism. Clin Sci 1999, 96:89-97.
17. Yaqoob P., Calder P.C. Cytokine production by human peripheral blood mononuclear cells: differential sensitivity to glutamine availability. Cytokine 1998, 10(10):790-794.
18. + DR++ monocytes are a major source of TNF. J Immunol 2002, 68(7):3536-3542.
19. West M.A., Heagy W. Endotoxin tolerance: a review. Crit Care Med 2002, 30(1):64-73.
20. Opal S.M., Scannon P.J., Vincent J.L., et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999, 180:1584.
21. Ameho C.K., Adjei A.A., Harrison E.K., et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
22. Asosa S., Mochizuki H., Yamamoto T., et al. A clinical study of the effectiveness of oral glutamine supplementation during total parenteral nutrition: influence on mesenteric mononuclear cells. J Parenter Enteral Nutr 1999, 23:41-44.
23. Andrew C., De Beaux F.R.C.S., Michael G., et al. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition 1998, 14:261-265.
24. Liang M., Wang X., Yuan Y., Zhou Q., Tong C., Jiang W. Different effect of glutamine on macrophage tumor necrosis factor-alpha release and heat shock protein 72 expression in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai) 2009, 41(2):171-177.
25. Exner Perioperative gly-gln infusion diminishes the surgery-induced period of immunosuppression: accelerated restoration of the LPS-stimulated tumor necrosis factor-alpha response. Ann Surg 2003, 137:110-115.
26. Vincent N., Martin G., Baverel G. Glycine, a new regulator of glutamine metabolism in isolated at-liver cells. Biochim Biophys Acta 1992, 1175:13-20.
27. Lechowski S., Feilhauer K., Staib L., Coëffier M., Bischoff S.C., Lorentz A. Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells. Eur J Nutr 2012, [Epub ahead of print].
28. Lecleire S., Hassan A., Marion-Letellier R., Antonietti M., Savoye G., Bôle-Feysot C., et al. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 2008, 138(12):2481-2486.
29. Hack C.E., De Groot E.R., Felt-Bersma R.J., Nuijens J.H., Strack Van Schijndel R.J., Eerenberg-Belmer A.J., et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989, 74(5):1704-1710.
30. Röntgen P., Sablotzki A., Simm A., Silber R.E., Czeslick E. Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur Cytokine Network 2004, 15(1):14-23.